JPH04297265A - Container with medicinal liquid - Google Patents
Container with medicinal liquidInfo
- Publication number
- JPH04297265A JPH04297265A JP3062777A JP6277791A JPH04297265A JP H04297265 A JPH04297265 A JP H04297265A JP 3062777 A JP3062777 A JP 3062777A JP 6277791 A JP6277791 A JP 6277791A JP H04297265 A JPH04297265 A JP H04297265A
- Authority
- JP
- Japan
- Prior art keywords
- container
- packaging material
- vinyl acetate
- ethylene
- pvc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 12
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims abstract description 43
- 239000005038 ethylene vinyl acetate Substances 0.000 claims abstract description 36
- 239000004800 polyvinyl chloride Substances 0.000 claims abstract description 21
- 239000004814 polyurethane Substances 0.000 claims abstract description 20
- 229920000915 polyvinyl chloride Polymers 0.000 claims abstract description 15
- 239000004698 Polyethylene Substances 0.000 claims abstract description 13
- 229920002635 polyurethane Polymers 0.000 claims abstract description 12
- 229920000578 graft copolymer Polymers 0.000 claims abstract description 10
- 229920003023 plastic Polymers 0.000 claims description 14
- 239000004033 plastic Substances 0.000 claims description 14
- 229920001756 Polyvinyl chloride acetate Polymers 0.000 claims description 6
- 239000008155 medical solution Substances 0.000 claims description 2
- -1 polyethylene Polymers 0.000 abstract description 17
- 239000000463 material Substances 0.000 abstract description 9
- 238000007789 sealing Methods 0.000 abstract description 8
- 230000000903 blocking effect Effects 0.000 abstract description 7
- 229920000573 polyethylene Polymers 0.000 abstract description 7
- 229920005989 resin Polymers 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 239000005022 packaging material Substances 0.000 description 35
- 238000000034 method Methods 0.000 description 12
- 229920000642 polymer Polymers 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 4
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 3
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 238000000071 blow moulding Methods 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920006254 polymer film Polymers 0.000 description 2
- 230000000379 polymerizing effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000007870 radical polymerization initiator Substances 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UFVWHIGSVGIZRQ-UHFFFAOYSA-N bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate Chemical compound C1=C(C(=O)OCC(CC)CCCC)C=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21 UFVWHIGSVGIZRQ-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- KVNRLNFWIYMESJ-UHFFFAOYSA-N butyronitrile Chemical compound CCCC#N KVNRLNFWIYMESJ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 229940021013 electrolyte solution Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000002794 monomerizing effect Effects 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000921 polyethylene adipate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Apparatus For Disinfection Or Sterilisation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、医薬液入り容器に関す
る。詳しく述べると、高圧蒸気滅菌処理が可能で、医薬
液を収容するプラスチック容器の外表面の無菌状態保存
および収容医薬液の空気による変質防止等に適した医薬
液入り容器に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to containers containing medicinal liquids. Specifically, the present invention relates to a container containing a medical liquid that can be subjected to high-pressure steam sterilization and is suitable for preserving the outer surface of the plastic container containing the medical liquid in a sterile state and for preventing the stored medical liquid from deteriorating due to air.
【0002】0002
【従来の技術】血液、輸液等やその他の医薬液を収容す
るプラスチック容器(内包材)の外表面を無菌状態に保
ったり、医薬液の空気中の酸素による変質を防いだりす
る目的で、該容器をさらに他の包装材料、特にプラスチ
ックフィルムやシート(外包材)で包み込み密封するこ
とが一般に行われている。内包材としては、柔軟な性質
のものが通常用いられ、軟質ポリ塩化ビニル、ポリエチ
レンおよびエチレン−酢酸ビニルコポリマーが代表的で
あるが、これら柔軟な性質を持つものは低軟化点(低融
点)、低ガラス転移点であるため、外包材で包んで高圧
蒸気滅菌処理する際に内包材が軟化して表面のタック性
が増すために内包材と外包材の接触面で融着が生じ、冷
却後もスティック・ブロックしたままの状態となって、
開封時(医薬液使用時)の操作が困難または不可能とな
りやすい等の問題がある。外包材の内壁の熱シール性の
向上のために低軟化点のポリマーを使うことがほとんど
であり、スティック現象はさらに助長される。[Prior Art] In order to keep the outer surface of a plastic container (inner packaging material) containing blood, infusion fluids, etc. It is common practice to further wrap and seal the container with another packaging material, particularly a plastic film or sheet (outer packaging material). As the inner packaging material, flexible materials are usually used, and flexible polyvinyl chloride, polyethylene, and ethylene-vinyl acetate copolymers are typical examples, but these flexible materials have low softening points (low melting points), Because it has a low glass transition point, when wrapped in an outer packaging material and subjected to high-pressure steam sterilization, the inner packaging material softens and the surface becomes tackier, resulting in fusion at the contact surface between the inner packaging material and the outer packaging material, and after cooling. The player remains stuck and blocked,
There are problems such as that it is difficult or impossible to operate when opening the package (when using the medicinal solution). In most cases, a polymer with a low softening point is used to improve the heat sealability of the inner wall of the outer packaging material, which further exacerbates the sticking phenomenon.
【0003】これを避けるには、■内包材および外包材
として高軟化点のポリマーを用いるか、■比較的マイル
ドな条件で滅菌処理をするか等が対策として考えられて
いるが、■については、熱シール性の低下のみならず、
高軟化点ポリマーは高剛性ポリマーということにつなが
りやすいため、プラスチック容器(内包材)の利点であ
る柔軟性が損なわれる。また、外包材としてポリエチレ
ンテレフタレートの如き比較的高融点(融点250〜2
60℃)のポリマーフィルムを用い、かつ■を組合せて
も内包材が前述の如き低軟化点ポリマーからなる場合は
ブロッキングを十分に抑制することは難しい。さらにポ
リエチレンテレフタレートの如き比較的高融点のポリマ
ーフィルムの場合、シール強度が低すぎるのも欠点であ
る。したがって、現状では、医薬液入り内包材の滅菌後
に、外包材で包み込む方法に拠らざるを得ず、内包材と
外包材の間の無菌性保障が難しくなる。[0003] In order to avoid this, measures have been considered such as (1) using polymers with a high softening point as the inner and outer packaging materials, and (2) sterilizing under relatively mild conditions. , as well as a decrease in heat sealability.
Since high softening point polymers tend to lead to high rigidity polymers, flexibility, which is an advantage of plastic containers (inner packaging materials), is lost. In addition, as an outer packaging material, polyethylene terephthalate, which has a relatively high melting point (melting point 250 to 2
Even if a polymer film with a temperature of 60° C.) is used and (1) is combined, it is difficult to sufficiently suppress blocking when the inner packaging material is made of a low softening point polymer as described above. A further disadvantage of relatively high melting point polymer films such as polyethylene terephthalate is that the sealing strength is too low. Therefore, at present, it is necessary to sterilize the inner packaging material containing the medicinal liquid and then wrap it in the outer packaging material, which makes it difficult to ensure sterility between the inner packaging material and the outer packaging material.
【0004】0004
【発明が解決しようとする課題】上述の如き状況から本
発明の目的は、耐ブロッキング性と良好なシール性を兼
備えた外包材を有する、内包材と外包材とで密封された
形態を持つ、高圧蒸気滅菌可能な医薬液入り容器を提供
することにある。[Problems to be Solved by the Invention] In light of the above-mentioned circumstances, an object of the present invention is to have an outer packaging material that has both anti-blocking properties and good sealing properties, and has a form that is sealed by an inner packaging material and an outer packaging material. An object of the present invention is to provide a container containing a medical liquid that can be sterilized by high-pressure steam.
【0005】[0005]
【課題を解決するための手段】上記諸目的は、医薬液を
収容する密封されたプラスチック容器(A)および該プ
ラスチック容器(A)を内包する密封されたフィルムま
たはシート(B)とからなる容器であって、該プラスチ
ック容器(A)がポリエチレンもしくはエチレン−酢酸
ビニルコポリマーで構成され、該フィルムまたはシート
(B)の少なくとも内壁がポリ塩化ビニルとエチレン−
酢酸ビニルコポリマーもしくはポリ塩化ビニルとポリウ
レタンとのグラフトコポリマーで形成されていることを
特徴とする医薬液入り容器によって達成される。[Means for Solving the Problems] The above objects are achieved by a container consisting of a sealed plastic container (A) containing a medicinal solution and a sealed film or sheet (B) enclosing the plastic container (A). The plastic container (A) is composed of polyethylene or ethylene-vinyl acetate copolymer, and at least the inner wall of the film or sheet (B) is composed of polyvinyl chloride and ethylene-vinyl acetate copolymer.
This is achieved by a container containing a pharmaceutical liquid, which is characterized by being formed of a vinyl acetate copolymer or a graft copolymer of polyvinyl chloride and polyurethane.
【0006】すなわち、本発明者らの検討の結果、ポリ
塩化ビニルとエチレン−酢酸ビニルコポリマーとのグラ
フトコポリマーあるいはポリ塩化ビニルとポリウレタン
とのグラフトコポリマーは、元来無可塑剤型軟質ポリ塩
化ビニルとして知られているポリマーであるが、これら
のフィルム(またはシート)がポリエチレン製あるいは
エチレン−酢酸ビニルコポリマー製の容器と高圧滅菌条
件下でもブロッキングし難いことが明らかとなった。特
に注目すべきことは、外包材としてのポリ塩化ビニルと
エチレン−酢酸ビニルコポリマーとのグラフトコポリマ
ーと内包材としてのエチレン−酢酸ビニルコポリマーと
の間でブロッキングが起こりにくいことである。That is, as a result of studies by the present inventors, the graft copolymer of polyvinyl chloride and ethylene-vinyl acetate copolymer or the graft copolymer of polyvinyl chloride and polyurethane was originally used as a plasticizer-free flexible polyvinyl chloride. Although these are known polymers, it has become clear that these films (or sheets) are difficult to block with polyethylene or ethylene-vinyl acetate copolymer containers even under high-pressure sterilization conditions. What is particularly noteworthy is that blocking is unlikely to occur between the graft copolymer of polyvinyl chloride and ethylene-vinyl acetate copolymer as the outer packaging material and the ethylene-vinyl acetate copolymer as the inner packaging material.
【0007】[0007]
【作用】本発明の内容をまず内包材(A)について説明
する。[Operation] The contents of the present invention will first be explained regarding the inner packaging material (A).
【0008】本発明で使用されるポリエチレンとしては
透明性、柔軟性などの点から低密度ポリエチレンが好適
であり、高圧法低密度ポリエチレン、プロピレン、ブテ
ン−1、ペンテン−1、ヘキセン−1、ヘプテン−1、
オクテン−1、4−メチル−1−ペンテン等のα−オレ
フィン類をコモノマー成分とする線状低密度ポリエチレ
ンがよい。そして成形性、耐熱性、力学的性質等をも考
慮すると密度が0.91〜0.94g/cm3で、温度
190℃、荷重2,160kgにおけるメルトフローレ
イト(以下MFRと称する)が0.1〜30、さらに好
ましくは0.2〜20のものがよい。エチレン−酢酸ビ
ニルコポリマー(以下EVAと称する)も同様の理由か
ら、酢酸ビニル含有量が3〜30重量%、好ましくは5
〜18重量%で、MFRがポリエチレンの場合と同じ0
.1〜30、好ましくは0.2〜20の範囲にあるもの
の使用がよい。[0008] As the polyethylene used in the present invention, low-density polyethylene is preferable from the viewpoint of transparency and flexibility, and high-pressure process low-density polyethylene, propylene, butene-1, pentene-1, hexene-1, heptene-1, etc. -1,
Linear low density polyethylene containing α-olefins such as octene-1, 4-methyl-1-pentene as a comonomer component is preferred. Considering moldability, heat resistance, mechanical properties, etc., the density is 0.91 to 0.94 g/cm3, and the melt flow rate (hereinafter referred to as MFR) at a temperature of 190°C and a load of 2,160 kg is 0.1. -30, more preferably 0.2-20. For the same reason, ethylene-vinyl acetate copolymer (hereinafter referred to as EVA) also has a vinyl acetate content of 3 to 30% by weight, preferably 5% by weight.
~18% by weight, with an MFR of 0, the same as that of polyethylene.
.. It is preferable to use a number in the range of 1 to 30, preferably 0.2 to 20.
【0009】ポリエチレンとEVAは単独で用いるのが
一般的であるが、必要により、これらの混合物あるいは
多層体であってもよい。また、耐熱性、力学的性質等の
向上の目的で放射線や有機過酸化物で架橋したものであ
ってもよい。[0009] Polyethylene and EVA are generally used alone, but a mixture or a multilayered body of these may be used if necessary. Further, it may be crosslinked with radiation or an organic peroxide for the purpose of improving heat resistance, mechanical properties, etc.
【0010】内包材(A)への成形は、通常公知の溶融
成形法である押出し法(インフレーション法,Tダイ法
)、射出成形法、ブロー成形法等で成形、製造されて、
その厚さは通常200〜800μm、好ましくは250
〜500μmである。[0010] The inner packaging material (A) is molded and manufactured by a commonly known melt molding method such as an extrusion method (inflation method, T-die method), an injection molding method, a blow molding method, etc.
Its thickness is usually 200 to 800 μm, preferably 250 μm.
~500 μm.
【0011】次に本発明では、外包材(B)の少なくと
も内壁がポリ塩化ビニルとエチレン−酢酸ビニルコポリ
マーとのグラフトポリマー(以下PVC−EVAと称す
る)もしくはポリ塩化ビニルとポリウレタンとのグラフ
トポリマー(以下PVC−PUと称する)で形成されて
いることを要件とするが、これは、少なくとも外包材の
内壁面、つまり内包材のポリエチレンもしくはEVAと
接触し得る部分が、PVC−EVAもしくはPVC−P
Uで形成されておればよいということであり、これらの
ポリマーからなる内層と他のポリマーからなる外層とが
直接または接着剤を介して貼り合わされた形態を有する
多層フィルムまたは多層シート構造のものであってもよ
い。この場合、他のポリマーはフィルムまたはシートの
力学的性質の向上、ガス(酸素、炭酸ガス、水蒸気など
)に対するバリヤー性の向上等の目的に応じて任意に選
ぶことができ、具体的にはポリエチレン、ポリプロピレ
ン、ポリ−1−ブテン、ポリ−4−メチル−1−ペンテ
ン、エチレン−酢酸ビニルコポリマー、エチレン−ビニ
ルアルコールコポリマー、ポリ塩化ビニリデン、ポリア
クリロニトリル、ナイロン6、ナイロン8、ナイロン1
2、ナイロン66、ナイロン610、ポリ−m−キシリ
レンアジパミド、ポリエチレンテレフタレート、ポリブ
チレンテレフタレート、ポリエチレン−2,6−ナフタ
レート、ポリ−1,4−シクロヘキシレンジメチレンテ
レフタレート等およびこれらを主成分とするコポリマー
が挙げられる。Next, in the present invention, at least the inner wall of the outer packaging material (B) is made of a graft polymer of polyvinyl chloride and ethylene-vinyl acetate copolymer (hereinafter referred to as PVC-EVA) or a graft polymer of polyvinyl chloride and polyurethane (hereinafter referred to as PVC-EVA). (hereinafter referred to as PVC-PU), which means that at least the inner wall surface of the outer packaging material, that is, the portion that can come into contact with the polyethylene or EVA of the inner packaging material, is made of PVC-EVA or PVC-PU.
It is sufficient that the material is made of U, and it has a multilayer film or multilayer sheet structure in which an inner layer made of these polymers and an outer layer made of other polymers are bonded directly or through an adhesive. There may be. In this case, other polymers can be arbitrarily selected according to the purpose of improving the mechanical properties of the film or sheet, improving the barrier properties against gases (oxygen, carbon dioxide, water vapor, etc.), and specifically, polyethylene , polypropylene, poly-1-butene, poly-4-methyl-1-pentene, ethylene-vinyl acetate copolymer, ethylene-vinyl alcohol copolymer, polyvinylidene chloride, polyacrylonitrile, nylon 6, nylon 8, nylon 1
2. Nylon 66, nylon 610, poly-m-xylylene adipamide, polyethylene terephthalate, polybutylene terephthalate, polyethylene-2,6-naphthalate, poly-1,4-cyclohexylene dimethylene terephthalate, etc., and these as main components Examples include copolymers of
【0012】PVC−EVAは、通常EVA(酢酸ビニ
ル含有量が20〜80重量%のものが好ましく用いられ
る)を幹ポリマーとし、これに塩化ビニルをグラフト重
合させて得られるものであり、例えば、EVAを塩化ビ
ニルモノマーに溶解して、アゾビスイソブチロニトリル
の如きラジカル重合開始剤で重合させることによって得
られる。なお、PVC−EVA中のEVA含有量は20
〜80重量%、好ましくは30〜75重量%がよい。ま
た、PVC−EVAの硬さは主として酢酸ビニル含有量
によって決まり、該含有量の多いものほど柔軟である。
そして成形性、力学的性質等を考慮すると数平均分子量
が30,000〜100,000、好ましくは40,0
00〜80,000のものがよい。[0012] PVC-EVA is usually obtained by graft polymerizing vinyl chloride onto EVA (preferably used with a vinyl acetate content of 20 to 80% by weight) as a backbone polymer; for example, It is obtained by dissolving EVA in a vinyl chloride monomer and polymerizing it with a radical polymerization initiator such as azobisisobutyronitrile. In addition, the EVA content in PVC-EVA is 20
~80% by weight, preferably 30-75% by weight. Further, the hardness of PVC-EVA is mainly determined by the vinyl acetate content, and the higher the vinyl acetate content, the softer it is. Considering moldability, mechanical properties, etc., the number average molecular weight is 30,000 to 100,000, preferably 40.0.
00 to 80,000 is preferable.
【0013】PVC−PUは、PVC−EVAと同様に
PVCが枝ポリマーであることが一般的である。ポリウ
レタンとしてはアジピン酸、アゼライン酸、セバシン酸
等のジカルボン酸成分と、エチレングリコール、プロピ
レングリコール、1,4−ブタンジオール、1,6−ヘ
キサンジオール、ジエチレングリコール、ポリエチレン
オキシド等のグリコール成分から成形されるポリエステ
ルジオール、またはポリエチレンオキシド、エチレンオ
キシド−プロピレンオキシドコポリマー、ポリテトラメ
チレンオキシド等のポリエーテルジオールをトルエンジ
イソシアネートや4,4´−ジフェニルメタンジイソシ
アネートと反応させて得られるものがよい。[0013] In PVC-PU, PVC is generally a branched polymer, similar to PVC-EVA. Polyurethane is molded from dicarboxylic acid components such as adipic acid, azelaic acid, and sebacic acid, and glycol components such as ethylene glycol, propylene glycol, 1,4-butanediol, 1,6-hexanediol, diethylene glycol, and polyethylene oxide. A polyester diol or one obtained by reacting a polyether diol such as polyethylene oxide, ethylene oxide-propylene oxide copolymer, or polytetramethylene oxide with toluene diisocyanate or 4,4'-diphenylmethane diisocyanate is preferable.
【0014】製法もPVC−EVAとほぼ同じで、この
ポリウレタンを幹ポリマーとし、これに塩化ビニルをグ
ラフト重合させて得られるものであり、例えば、ポリウ
レタンを塩化ビニルモノマーに溶解して、アゾビスイソ
ブチロニトリルの如きラジカル重合開始剤で重合させる
ことによって得られる。PVC−PUの硬さはポリウレ
タンの組成、含有量によって決まる。そして成形性、力
学的性質等を考慮するとポリウレタン含有量は20〜8
0重量%、好ましくは30〜70重量%であり、温度1
80℃、せん断速度100sec−1における溶融粘度
が10,000〜50,000ポイズ、好ましくは15
,000〜40,000ポイズ程度のものがよい。The manufacturing method is almost the same as PVC-EVA, and it is obtained by using this polyurethane as a backbone polymer and grafting vinyl chloride onto it. For example, polyurethane is dissolved in vinyl chloride monomer and azobisiso It can be obtained by polymerization with a radical polymerization initiator such as butyronitrile. The hardness of PVC-PU is determined by the composition and content of polyurethane. Considering moldability, mechanical properties, etc., the polyurethane content is 20 to 8.
0% by weight, preferably 30-70% by weight, and at a temperature of 1
Melt viscosity at 80°C and shear rate of 100 sec-1 is 10,000 to 50,000 poise, preferably 15
,000 to 40,000 poise is preferable.
【0015】PVC−EVAやPVC−PUのフィルム
またはシート(B)への成形は、内包材の場合と同様に
、溶融成型法である押出し法(インフレーション法,T
ダイ法)、射出成形法、ブロー成形法等で成形、製造さ
れて、成形温度としては150〜200℃が適当である
。また、一般のPVCの場合と同様にカレンダー加工法
やロール加工法も適用され得る。[0015] PVC-EVA or PVC-PU is molded into a film or sheet (B) using the extrusion method (inflation method, T
It is molded and manufactured by a die method), an injection molding method, a blow molding method, etc., and a suitable molding temperature is 150 to 200°C. Further, as in the case of general PVC, calender processing and roll processing may also be applied.
【0016】これらの成形においては、通常のPVCの
安定化のために使用される添加剤、例えば、カルシウム
、亜鉛等の塩類、亜リン酸エステル、酸化防止剤、紫外
線吸収剤等を添加してもよいことは言うまでもない。[0016] In these moldings, additives commonly used to stabilize PVC, such as salts such as calcium and zinc, phosphite esters, antioxidants, and ultraviolet absorbers, are added. Needless to say, it's a good thing.
【0017】上記グラフトポリマーは、軟質PVCと変
わらない柔軟性を持っており、必ずしも可塑剤の添加を
必要としないが、もし必要であれば、例えばポリエチレ
ナジペート系、ポリブチレンアジペート系等の分子量1
,000以上のポリエステルタイプ可塑剤を添加するの
が好ましく、ジエチルヘキシルナフタレートのような分
子量500以下の低分子量可塑剤の添加は、移行性の問
題があるため避けることが好ましい。The above-mentioned graft polymer has the same flexibility as flexible PVC, and does not necessarily require the addition of a plasticizer, but if necessary, the molecular weight of polyethylene adipate, polybutylene adipate, etc. 1
,000 or more is preferable, and it is preferable to avoid adding a low molecular weight plasticizer such as diethylhexyl naphthalate, which has a molecular weight of less than 500, because it may cause migration problems.
【0018】外包材のフィルムまたはシート(B)は、
PVC−EVAもしくはPVC−PU部分の厚さが5μ
m以上で、単層または他のフィルムまたはシートとの多
層構造である。また、多層フィルムまたは多層シート等
にして用いる場合は全体の厚さが0.01〜0.5mm
程度、好ましくは0.05〜0.3mmであるようにす
ることがよい。また、この外包材のフィルムまたはシー
ト(B)のシール法としては、通常PVCフィルム(ま
たはシート)に適用されるシール法、例えばインパルス
シール法や高周波シール法が採用され得る。特に、高周
波シール法はPVC、EVA、ポリウレタン共に誘電力
率が大きいので容易である。[0018] The outer packaging material film or sheet (B) is
Thickness of PVC-EVA or PVC-PU part is 5μ
m or more, and is a single layer or a multilayer structure with other films or sheets. In addition, when used as a multilayer film or multilayer sheet, the total thickness is 0.01 to 0.5 mm.
It is preferable to adjust the thickness to about 0.05 to 0.3 mm. Further, as a sealing method for the film or sheet (B) of the outer packaging material, a sealing method normally applied to PVC films (or sheets), such as an impulse sealing method or a high frequency sealing method, can be adopted. In particular, the high frequency sealing method is easy because PVC, EVA, and polyurethane all have a high dielectric constant.
【0019】本発明において、内包材(A)と外包材の
フィルムまたはシート(B)の間の雰囲気は真空(減圧
)や窒素ガス、炭酸ガス充填等用途、要求に応じて任意
に選ぶことができる。用いられる医薬液としては、生理
食塩水、電解質液、デキストラン製剤、マンニトール製
剤、糖類製剤、アミノ酸製剤等が好適例として挙げられ
る。高圧蒸気滅菌は、通常、ゲージ圧1.2〜20kg
/cm2の圧力下で100〜130℃で行なわれる。In the present invention, the atmosphere between the inner wrapping material (A) and the outer wrapping material film or sheet (B) can be arbitrarily selected depending on the application and requirements, such as vacuum (reduced pressure), nitrogen gas, carbon dioxide gas filling, etc. can. Suitable examples of the medicinal solution used include physiological saline, electrolyte solutions, dextran preparations, mannitol preparations, saccharide preparations, amino acid preparations, and the like. High-pressure steam sterilization usually uses a gauge pressure of 1.2 to 20 kg.
It is carried out at 100-130°C under a pressure of /cm2.
【0020】[0020]
【実施例】以下、実施例によって本発明をさらに具体的
に説明する。[Examples] The present invention will be explained in more detail below with reference to Examples.
【0021】実施例1〜6および比較例1〜2(1)実
験法
■プラスチック容器(内包材)(A)の成形表1に示す
如き材質で構成される。まず、表1のペレットをエクス
トルーダー型溶融押出し機(池貝鉄工株式会社製)に供
給し、温度180℃、径8cm、リップ幅1.5mmの
サーキュラーダイから押出し、20℃の水で冷却後、厚
さ350μm、析出径16cmのチューブ状シートを得
、熱板法でシールをして、約2.5cm×14cm×3
0cmの偏平状の形状の容器を成形した。
これに、1000mlの生理食塩水を内臓させた。Examples 1 to 6 and Comparative Examples 1 to 2 (1) Experimental method (1) Molding of plastic container (inner packaging material) (A) The container was made of the materials shown in Table 1. First, the pellets shown in Table 1 were fed to an extruder-type melt extruder (manufactured by Ikegai Iron Works Co., Ltd.), extruded through a circular die with a temperature of 180°C, a diameter of 8cm, and a lip width of 1.5mm, and after cooling with water at 20°C, A tubular sheet with a thickness of 350 μm and a deposition diameter of 16 cm was obtained, and sealed using a hot plate method to form a sheet of approximately 2.5 cm x 14 cm x 3.
A container with a flat shape of 0 cm was molded. This was filled with 1000 ml of physiological saline.
【0022】■外包材(B)(または(C))の成形表
2に示す如き材質で構成される。まず、表2のペレット
をエクストルーダー型溶融押出し機(池貝鉄工株式会社
製)に供給し、温度180℃で、径8cm、リップ幅1
.0mmのダイから押出し、20℃の水で冷却後、厚さ
100μm、析出径18cmのチューブ状とし巻き取っ
た。(2) Forming of outer packaging material (B) (or (C)) It is composed of the materials shown in Table 2. First, the pellets shown in Table 2 were fed to an extruder-type melt extruder (manufactured by Ikegai Tekko Co., Ltd.), and at a temperature of 180°C, a diameter of 8 cm and a lip width of 1
.. The product was extruded through a 0 mm die, cooled with water at 20° C., formed into a tube with a thickness of 100 μm and a deposit diameter of 18 cm, and wound up.
【0023】■医薬液入り容器の調製
(A)を(B)(または(C))で真空包装し、インパ
ルスシールした。(2) Preparation of a container containing a medical solution (A) was vacuum-packed with (B) (or (C)) and impulse-sealed.
【0024】■滅菌
レトルト型高圧蒸気滅菌器を用いて、温度115℃、ゲ
ージ圧1.8kg/cm2で、30分間行った。圧力の
確保は窒素ガスで飽和水蒸気を加圧する方法に拠る。[0024] Sterilization Sterilization was carried out using a retort type high-pressure steam sterilizer at a temperature of 115°C and a gauge pressure of 1.8 kg/cm2 for 30 minutes. The pressure is secured by pressurizing saturated steam with nitrogen gas.
【0025】■ブロッキング現象の観察滅菌後冷却した
医薬液入り容器について内包材(A)と外包材(B)(
または(C))を引き剥がして、ブロッキングが起こっ
ているか否かを判定した。■ Observation of Blocking Phenomenon Inner packaging material (A) and outer packaging material (B) (
Or (C)) was peeled off to determine whether blocking had occurred.
【0026】[0026]
【表1】[Table 1]
【0027】[0027]
【表2】[Table 2]
【0028】(2)結果
表3に各種包装材料の組合せとブロッキングの有無との
関係を示す。表3より明らかなように、PVC−EVA
およびPVC−PU製がEVAやポリエチレン製のプラ
スチック容器に対してブロッキングの問題を起こさず、
有効な外包材であることがわかる。(2) Results Table 3 shows the relationship between the combinations of various packaging materials and the presence or absence of blocking. As is clear from Table 3, PVC-EVA
And PVC-PU does not cause blocking problems with EVA or polyethylene plastic containers.
It can be seen that it is an effective outer packaging material.
【0029】[0029]
【表3】[Table 3]
【0030】[0030]
【発明の効果】以上述べた如く、本発明は、医薬液を収
容する密封されたプラスチック容器(A)および該プラ
スチック容器(A)を内包する密封されたフィルムまた
はシート(B)とからなる容器であって、該プラスチッ
ク容器(A)がポリエチレンもしくはエチレン−酢酸ビ
ニルコポリマーで構成され、該フィルムまたはシート(
B)の少なくとも内壁がポリ塩化ビニルとエチレン−酢
酸ビニルコポリマーもしくはポリ塩化ビニルとポリウレ
タンとのグラフトコポリマーで形成されていることを特
徴とする医薬液入り容器であるから、高圧蒸気滅菌が可
能であり、無菌状態保存、薬液の変質防止等に役立ち、
かつ医薬液を収容する密封されたプラスチック容器(A
)とフィルムないしシート(B)との間のブロッキング
がなく、さらにPVC−EVAおよびPVC−PUの持
つ柔軟性や透明性と相まってその工業的価値は高いもの
である。As described above, the present invention provides a container comprising a sealed plastic container (A) containing a medicinal solution and a sealed film or sheet (B) enclosing the plastic container (A). The plastic container (A) is composed of polyethylene or ethylene-vinyl acetate copolymer, and the film or sheet (A) is composed of polyethylene or ethylene-vinyl acetate copolymer.
B) is a container containing a medicinal liquid characterized in that at least the inner wall is formed of a polyvinyl chloride and ethylene-vinyl acetate copolymer or a graft copolymer of polyvinyl chloride and polyurethane, so that high-pressure steam sterilization is possible. , useful for preserving aseptic conditions and preventing deterioration of medicinal solutions.
and a sealed plastic container (A
) and the film or sheet (B), and combined with the flexibility and transparency of PVC-EVA and PVC-PU, its industrial value is high.
Claims (1)
ック容器(A)および該プラスチック容器(A)を内包
する密封されたフィルムまたはシート(B)とからなる
容器であって、該プラスチック容器(A)がポリエチレ
ンもしくはエチレン−酢酸ビニルコポリマーで構成され
、該フィルムまたはシート(B)の少なくとも内壁がポ
リ塩化ビニルとエチレン−酢酸ビニルコポリマーもしく
はポリ塩化ビニルとポリウレタンとのグラフトコポリマ
ーで形成されていることを特徴とする医薬液入り容器。1. A container consisting of a sealed plastic container (A) containing a medical solution and a sealed film or sheet (B) enclosing the plastic container (A), the container comprising: ) is composed of polyethylene or ethylene-vinyl acetate copolymer, and at least the inner wall of the film or sheet (B) is composed of polyvinyl chloride and ethylene-vinyl acetate copolymer or a graft copolymer of polyvinyl chloride and polyurethane. Container containing medicinal liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3062777A JPH04297265A (en) | 1991-03-27 | 1991-03-27 | Container with medicinal liquid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3062777A JPH04297265A (en) | 1991-03-27 | 1991-03-27 | Container with medicinal liquid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04297265A true JPH04297265A (en) | 1992-10-21 |
Family
ID=13210140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3062777A Pending JPH04297265A (en) | 1991-03-27 | 1991-03-27 | Container with medicinal liquid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04297265A (en) |
-
1991
- 1991-03-27 JP JP3062777A patent/JPH04297265A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2501308B2 (en) | Chemically stabilized film | |
CA2184868C (en) | Pvc-free multilayer tube for medical purposes, process for the production thereof and use | |
CA1332051C (en) | Package units for medicinal purposes | |
US4401536A (en) | Biocompatible, steam-sterilizable irradiated articles comprised of ethylene copolymer and polypropylene blends | |
US4528220A (en) | Plastic bags for medical solutions and blood | |
US4540416A (en) | Heat-sterilizable polyolefin compositions and articles manufactured therefrom | |
JP2550256B2 (en) | Medical bag | |
US4891253A (en) | Moisture barrier medical film | |
JPH0553510B2 (en) | ||
JP2003528194A (en) | Autoclavable, non-stick, heat-sealable polymer blend for making monolayer and multilayer films | |
US4536549A (en) | Heat-sterilizable polyolefin compositions and articles manufactured therefrom | |
JP2716514B2 (en) | Laminate | |
JP4323590B2 (en) | Medical multi-chamber container | |
JP3549643B2 (en) | Medical substrate | |
JPH04297265A (en) | Container with medicinal liquid | |
JP3006182B2 (en) | Medical bag | |
JPH0531156A (en) | Container containing medicine solution | |
JPH04319359A (en) | Vessel containing liquid medicine | |
JPH04197358A (en) | Container filled with medical liquid | |
JPH0999036A (en) | Vessel for medical treatment | |
KR102239192B1 (en) | Co-extrusion, Medical Film with Multilayer Structure | |
JPH04292170A (en) | Base material for medical use container | |
JPH04197357A (en) | Container filled with medical liquid | |
JPH06171040A (en) | Polyolefin-based base material for medical container | |
JPH0118740B2 (en) |